BRAINXPLORE

Discover the latest news from Etap-LAB

Contact an expert

Published on the 17 January 2017

Alpha synuclein Parkinson disease and pure autonomic failure in patients

To characterize the expression in skin nerves of native (n-syn) and misfolded phosphorylated (p-syn) α-synucleins in pure autonomic failure (PAF) and idiopathic Parkinson disease (IPD). The specific a…

Science and innovation
Published on the 11 November 2016

Parkinson 6 OHDA preclinical: New POC on rat to repair neurons, with new compound.

Researchers from the college of Pharmaceutical Sciences in China have recently studied a compound that enhances neuronal recovery in a rat model of Parkinson’s disease (Parkinson 6 OHDA). Parkinson’s…

Science and innovation
Published on the 3 November 2016

Join Syncrosome team at Bio-Europe in Cologne, Germany, next week!

Syncrosome invites you to visit us at Bio-Europe, November 7th to November 9th 2016, in Cologne, Germany. Emmanuelle Bettendorf, our Business Developer would be delighted to meet you their and discus…

Events
Published on the 11 October 2016

BACK from the 2nd Annual Neuroscience R&D Technologies Conference

Syncrosome, participated last week to the Neuroscience R&D Technologies Conference in London, to present key Parkinson's data. It was 2 very interesting days spent to discuss about the new adva…

Science and innovation
Published on the 5 September 2016

Syncrosome & the 2nd Annual Neuroscience Conference.

As you know Syncrosome is a preclinical CRO managing efficacy in vivo/ in vitro studies with more than 15 disease models validated in house and reproducible. Syncrosome is involved in Central Nervous…

Events
Published on the 31 March 2016

Immunization therapies, synuclein and Parkinson’s disease – multiple system atrophy

Vaccination is increasingly being investigated as a potential treatment for synucleinopathies, a group of neurodegenerative diseases including Parkinson's disease, multiple system atrophy, and dementi…

Science and innovation
Published on the 22 March 2016

Synucleopathies and preclinical Parkinson disease models

Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies, have all something in common. They all belong to a group of neurodegenerative diseases called synucleinopathies, including p…

Science and innovation
Published on the 16 March 2016

Neuroprotective effects of Omega-3 on 6 OHDA Parkinson preclinical mice.

Researchers from the CHU Research centre in Quebec have shown that diet can play a neuroprotective role in a preclinical Parkinson mouse model. They investigated the effects of a omega-3 polyunsaturat…

Science and innovation

Discover our scientific resources and browse posters…

Discover our resources